Contrast-enhanced ultrasonographic assessment of the response of Ménétrier disease to Helicobacter pylori eradication therapy.
Kuzuya
Teiji
T
Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Gifu 503-8502, Japan.
Kumada
Takashi
T
Kiriyama
Seiki
S
Sone
Yasuhiro
Y
Tanikawa
Makoto
M
Hisanaga
Yasuhiro
Y
Toyoda
Hidenori
H
Hayashi
Kazuhiko
K
Nonogaki
Koji
K
Shimizu
Junichi
J
Kawase
Naoto
N
Yamauchi
Takahiro
T
Kawachi
Toshiaki
T
Ichikawa
Hideo
H
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000627:therapeutic use; D000658:Amoxicillin / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D003287:Contrast Media; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D016099:Endoscopy, Gastrointestinal; D005260:Female; D005758:Gastritis, Hypertrophic / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D064747:Lansoprazole; D008875:Middle Aged; D011134:Polysaccharides; D014463:Ultrasonography
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D003287:Contrast Media; D011134:Polysaccharides; D064747:Lansoprazole; C059891:SHU 508; D000658:Amoxicillin; D017291:Clarithromycin